Latest stories on ZLDPF
Generate, Zealand in collaboration to develop drugs for obesity, metabolic diseases
Seeking Alpha63 · neutralproduct/pr
Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion
Bloomberg64 · neutralm&a
Petrelintide Phase III Trial Puts Zealand Pharma in the Weight-Loss Spotlight
TipRanks73 · bullishproduct/pr
Zealand Pharma opens research hub in Cambridge, Massachusetts
The Fly56 · neutralproduct/pr
Premarket movers: Alphabet rises on new AI model, Zealand Pharma sinks
Investing.com Markets62 · neutralproduct/pr
Why is Zealand Pharma stock sliding today?
Investing.com Markets42 · neutralgeneral
Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results
MarketWatch34 · bearishgeneral
Zealand Pharma shares fall 12% after obesity drug trial flags side effects
Investing.com Markets38 · neutralearnings
Total number of shares and voting rights in Zealand Pharma as of September 30, 2026
GlobeNewswire50 · neutralgeneral
Zealand Pharma: A Play On Medicine Discovery, But Too Expensive Right Now
Seeking Alpha48 · neutralanalyst
Zealand Pharma downgraded to Equal Weight from Overweight at Barclays
The Fly38 · neutralanalyst
Barclays cuts Zealand Pharma stock rating on distant catalysts
Investing.com Analyst Ratings34 · bearishanalyst
Zealand Pharma price target lowered to DKK 435 from DKK 460 at JPMorgan
The Fly42 · neutralanalyst
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
The Fly55 · neutralm&a
Zealand Pharma price target raised to DKK 420 from DKK 410 at Wells Fargo
The Fly63 · neutralanalyst
Zealand Pharma GAAP EPS of DKK55.34, revenue of DKK4.49B
Seeking Alpha50 · neutralearnings
Zealand Pharma A/S 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Zealand Pharma Announces Financial Results for the First Half of 2026
Business Insider50 · neutralearnings
Zealand Pharma Announces Financial Results for the First Half of 2026
GlobeNewswire56 · neutralearnings
Royalty Pharma, Zealand Pharma Enter Rusfertide Funding Agreement
MarketWatch55 · neutralgeneral
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
Business Insider59 · neutralgeneral